K14-EGPF-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression

International Journal of Cancer

Volumn 136, Issue 6, 2015, Pages 1263-1275

  Tseng, Ssu Hsueh ^a   Yang, Cheng Chieh ^a,c   Yu, En Hao ^a   Chang, Christine ^a   Lee, Yong Syu ^a   Liu, Chung Ji ^a,b   Chang, Kuo Wei ^a,c   Lin, Shu Chun ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Ku80; MicroRNA; miR 31; Mouth; PARP1; Transgenic mouse

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ENHANCED GREEN FLUORESCENT PROTEIN; HISTONE H2AX; MICRORNA 31; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; CELL NUCLEUS ANTIGEN; DNA BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; H2AFX PROTEIN, HUMAN; HISTONE; KU ANTIGEN; MICRORNA; MIRN31 MICRORNA, HUMAN; MIRN31 MICRORNA, MOUSE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; KU80 GENE; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PARP1 GENE; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA CELL LINE; SQUAMOUS EPITHELIUM; TONGUE CARCINOMA; TRANSGENIC MOUSE; X IRRADIATION; YOUNG ADULT; ANIMAL; CHEMICALLY INDUCED; ESOPHAGUS TUMOR; METABOLISM; MOUTH TUMOR; PHYSIOLOGY; TUMOR CELL LINE;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTIGENS, NUCLEAR; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA DAMAGE; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; GREEN FLUORESCENT PROTEINS; HISTONES; HUMANS; MICE; MICE, TRANSGENIC; MICRORNAS; MOUTH NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES;

EID: 84922244048     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29106     Document Type: Article

References (46)

1. Freier K, Joos S, Flechtenmacher C, et al. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 2003;63:1179-82.
2. Liu CJ, Tsai MM, Hung PS, et al. miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 2010;70:1635-44.
3. Lo WL, Yu CC, Chiou GY, et al. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol 2011;223:482-95.
4. Yang WH, Lan HY, Huang CH, et al. RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol 2012;14:366-74.
5. Liu CJ, Shen WG, Peng SY, et al. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene. Int J Cancer 2014;134:811-21.
6. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011;11:9-22.
7. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33.
8. Liu CJ, Kao SY, Tu HF, et al. Increase of micro-RNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 2010;16:360-4.
9. Hung PS, Tu HF, Kao SY, et al. miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes. Carcinogenesis 2014; 35:1161-71.
10. Sun D, Yu F, Ma Y, et al. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol Chem 2013;288:9508-18.
11. Liu X, Sempere LF, Ouyang H, et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010;120:1298-309.
12. Alder H, Taccioli C, Chen H, et al. Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis 2012;33:1736-44.
13. Saad R, Chen Z, Zhu S, et al. Deciphering the unique microRNA signature in human esophageal adenocarcinoma. PLoS One 2013;8:e64463.
14. Bruegger C, Kempf W, Spoerri I, et al. Micro-RNA expression differs in cutaneous squamous cell carcinomas and healthy skin of immunocompetent individuals. Exp Dermatol 2013;22:426-8.
15. Cottonham CL, Kaneko S, Xu L. miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem 2010;285:35293-302.
16. Xu RS, Wu XD, Zhang SQ, et al. The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer. Int J Oncol 2013;42:676-82.
17. Valastyan S, Reinhardt F, Benaich N, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009;137:1032-46.
18. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol 2010;11:220-8.
19. Gorgoulis VG, Vassiliou LV, Karakaidos P, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005;434:907-13.
20. Jenkins G, O'Byrne KJ, Panizza B, et al. Genome stability pathways in head and neck cancers. Int J Genomics 2013;2013:464720.
21. Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature 2012;481:287-94.
22. Moeller BJ, Yordy JS, Williams MD, et al. DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy. Clin Cancer Res 2011;17:2035-43.
23. Kuo LJ, Yang LX. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In Vivo 2008;22:305-9.
24. Sarver AL, French AJ, Borralho PM, et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 2009;9:401.
25. Nosho K, Igarashi H, Nojima M, et al. Association of microRNA-31 with BRAF mutation, colorectal-cancer survival and serrated pathway. Carcinogenesis 2014;35:776-83.
26. Jones CJ, Edwards SM, Waters R. The repair of identified large DNA adducts induced by 4-nitroquinoline-1-oxide in normal or xeroderma pigmentosum group A human fibroblasts, and the role of DNA polymerases alpha or delta. Carcinogenesis 1989;10:1197-201.
27. Arima Y, Nishigori C, Takeuchi T, et al. 4-Nitroquinoline 1-oxide forms 8-hydroxydeoxyguanosine in human fibroblasts through reactive oxygen species. Toxicol Sci 2006;91:382-92.
28. Kanojia D, Vaidya MM. 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. Oral Oncol 2006;42:655-67.
29. Tang XH, Knudsen B, Bemis D, et al. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res 2004;10:301-13.
30. Chu TH, Yang CC, Liu CJ, et al. miR-211 promotes the progression of head and neck carcinomas by targeting TGFbetaRII. Cancer Lett 2013;337:115-24.
31. Collins TJ. ImageJ for microscopy. Biotechniques 2007;43:25-30.
32. Pham NA, Morrison A, Schwock J, et al. Quantitative image analysis of immunohistochemical stains using a CMYK color model. Diagn Pathol 2007;2:8.
33. Lu HH, Kao SY, Liu TY, et al. Areca nut extract induced oxidative stress and upregulated hypoxia inducing factor leading to autophagy in oral cancer cells. Autophagy 2010;6:725-37.
34. Lynam-Lennon N, Reynolds JV, Marignol L, et al. MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma. J Mol Med 2012;90:1449-58.
35. Bian Y, Hall B, Sun ZJ, et al. Loss of TGF-beta signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene 2011;31:3322-32.
36. Bornstein S, White R, Malkoski S, et al. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J Clin Invest 2009;119:3408-19.
37. Herzog A, Bian Y, Vander Broek R, et al. PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer. Clin Cancer Res 2013;19:3808-19.
38. Moynahan ME. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. Oncogene 2002;21:8994-9007.
39. van Steeg H, de Vries A, van Oostrom C, et al. DNA repair-deficient Xpa and Xpa/p53+/-knock-out mice: nature of the models. Toxicol Pathol 2001;29 Suppl:109-16.
40. Krishnan K, Steptoe AL, Martin HC, et al. Micro-RNA-182-5p targets a network of genes involved in DNA repair. RNA 2013;19:230-42.
41. Brunner S, Herndler-Brandstetter D, Arnold CR, et al. Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8(+) T cells sensitizing them to apoptotic cell death. Aging Cell 2012;11:579-87.
42. Yan D, Ng WL, Zhang X, et al. Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One 2010;5:e11397.
43. Gunji A, Uemura A, Tsutsumi M, et al. Parp-1 deficiency does not increase the frequency of tumors in the oral cavity and esophagus of ICR/129Sv mice by 4-nitroquinoline 1-oxide, a carcinogen producing bulky adducts. Cancer Lett 2006;241:87-92.
44. Robu M, Shah RG, Petitclerc N, et al. Role of poly(ADP-ribose) polymerase-1 in the removal of UV-induced DNA lesions by nucleotide excision repair. Proc Natl Acad Sci U S A 2013;110:1658-63.
45. Sachs N, Secades P, van Hulst L, et al. Reduced susceptibility to two-stage skin carcinogenesis in mice with epidermis-specific deletion of cd151. J Invest Dermatol 2014;134:221-8.
46. Chan YT, Lin YC, Lin RJ, et al. Concordant and discordant regulation of target genes by miR-31 and its isoforms. PLoS One 2013;8:e58169.